| Baseline | After 8 weeks of ingestion | Standard value | ||
TSE | Placebo | TSE | Placebo |
| |
Total protein (g/dL) | 7.2 ± 0.3 | 7.3 ± 0.4 | 7.0 ± 0.4 | 7.3 ± 0.4* | 6.7 - 8.3 |
Total bilirubin (mg/dL) | 0.96 ± 0.55 | 0.80 ± 0.25 | 0.88 ± 0.31 | 0.86 ± 0.32 | 0.2 - 1.2 |
Urea N (mg/dL) | 12.7 ± 3.1 | 12.6 ± 3.1 | 12.4 ± 3.0 | 13.0 ± 2.8 | 8 - 20 |
Creatinine (mg/dL) | 0.61 ± 0.07 | 0.62 ± 0.08 | 0.59 ± 0.08 | 0.61 ± 0.08 | 0.47 - 0.79 |
Uric acid (mg/dL) | 4.1 ± 1.0 | 4.2 ± 0.9 | 3.9 ± 1.0 | 4.2 ± 1.0 | 2.5 - 7.0 |
Total cholesterol (mg/dL) | 235 ± 27 | 228 ± 34 | 239 ± 24 | 238 ± 35 | 120 - 219 |
LDL cholesterol (mg/dL) | 141 ± 25 | 133 ± 33 | 145 ± 24 | 140 ± 34 | 65 - 139 |
HDL cholesterol (mg/dL) | 75 ± 15 | 80 ± 21 | 78 ± 15 | 83 ± 21 | 40 - 95 |
Triglyceride (mg/dL) | 109 ± 81 | 78 ± 30 | 86 ± 41 | 78 ± 34 | 30 - 149 |
HbA1c (%) | 5.3 ± 0.3 | 5.4 ± 0.3 | 5.3 ± 0.3 | 5.4 ± 0.3 | 4.6 - 6.2 |
Glycoalbumin (%) | 14.2 ± 1.4 | 14.2 ± 1.6 | 13.7 ± 1.5 | 13.7 ± 1.3 | 12.3 - 16.5 |
Blood glucose (mg/dL) | 85 ± 10 | 84 ± 6 | 88 ± 15 | 83 ± 8 | 70 - 109 |
Amylase (U/L) | 88 ± 25 | 86 ± 31 | 91 ± 30 | 85 ± 24 | 40 - 122 |
CK (U/L) | 96 ± 52 | 108 ± 53 | 88 ± 45 | 116 ± 50 | 40 - 150 |
AST (U/L) | 20.7 ± 7.8 | 21.3 ± 4.5 | 20.6 ± 6.5 | 21.8 ± 5.7 | 10 - 40 |
ALT (U/L) | 16.5 ± 10.0 | 17.0 ± 9.7 | 16.7 ± 8.8 | 17.1 ± 10.1 | 5 - 45 |
γ-GTP (U/L) | 15.6 ± 4.0 | 17.0 ± 7.2 | 15.6 ± 4.3 | 17.7 ± 7.9 | <30 |
ALP (U/L) | 173 ± 56 | 201 ± 61 | 165 ± 52 | 201 ± 65 | 100 - 325 |
LAP (U/L) | 47 ± 7 | 49 ± 6 | 46 ± 6 | 50 ± 5 | 37 - 61 |
LDH (U/L) | 187 ± 32 | 191 ± 23 | 183 ± 31 | 197 ± 24 | 120 - 240 |
Na (mEq/L) | 140 ± 2 | 140 ± 2 | 141 ± 2 | 140 ± 1 | 137 - 147 |
K (mEq/L) | 4.1 ± 0.3 | 4.2 ± 0.3 | 4.2 ± 0.2 | 4.2 ± 0.3 | 3.5 - 5.0 |
Cl (mEq/L) | 100 ± 2 | 100 ± 2 | 101 ± 2 | 101 ± 1 | 98 - 108 |
Ca (mg/dL) | 9.1 ± 0.4 | 9.3 ± 0.3 | 9.3 ± 0.3 | 9.4 ± 0.3 | 8.4 - 10.4 |
Fe (µg/dL) | 102 ± 28 | 103 ± 25 | 90 ± 33 | 102 ± 33 | 40 - 180 |
Inorganic P (mg/dL) | 3.8 ± 0.5 | 3.5 ± 0.5 | 3.7 ± 0.3 | 3.4 ± 0.4 | 2.5 - 4.5 |